Back to top

Image: Bigstock

PerkinElmer, Inc.

Read MoreHide Full Article

PerkinElmer reported modest third-quarter 2015 results. The company continues to execute its business strongly across several product lines aided by rebounding markets and effective cost-containment efforts. With an enhanced focus on product innovation and improving end-market trends, PerkinElmer has considerable potential upside. Strategic collaborations with the likes of Johnson & Johnson and Albany Molecular as well as accretive acquisitions are also expected to drive growth in 2015 and beyond. However, owing to the strengthening of the U.S. dollar, sluggish European macro-environment, challenges in Japan will hurt top-line growth in the near term.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

PerkinElmer, Inc. (PKI) - free report >>

Published in